TODAY : Monday, 21 April 2025
Code
SDPC
Title
PT. Millennium Pharmacon International Tbk
Address
Head Office:
Address:Crown Bungur Arteri 2-4th Floor
Jl. Sultan Iskandar Muda No.18 Kel. Kebayoran Lama Selatan, Jakarta Selatan 12220
Phone:(021) 270 85961; 270 85964
Fax:(021) 270 85958
E-mail:investor.relation@mpi-pharmaniaga.co.id
Website:www.mpi-indonesia.co.id
Operation Office:
Jl. Duta Niaga Kav. 3 Blok BA / 43 - 44
Pondok Indah - Jakarta
Phone:
Fax:
E-mail:ernie@mail.sdpc.co.id
Website:www.mpi-indonesia.co.id
Background

The Company is engaged in distribution and trading of prescription medicine, non-prescription medicine and medical devices.
Business cp product

The Company is engaged in distribution and trading of prescription medicine, non-prescription medicine and medical devices.
Subsidiary affiliation
Commissioners
President Commissioner/Ind: Joefly Joesoef Bahroeny
Commissioner: Zulkifli Bin Jafar
Independent Commissioner: Aman Bhakti Pulungan
Independent Commissioner: Drs. Imam Fathorrahman, MM
Independent Commissioner: Sarah Azreen Binti Abdul Samat
Per 30 Sep 2022
Directors
President Director: Ahmad Bin Abu Bakar
Director: Mohamad Fazly Bin Hassan
Per 30 Sep 2022
Underwriter
PT. Danareksa
PT. Wardley James Capel Indonesia
Share registrar
PT. Sirca Datapro Perdana
PT. Raya Saham Registra
Share holders
ShareholdersShares%
Pharmaniaga Int. Corp.Sdn.Bhd93554153473.43
PT Danpac Pharma1238440209.72
Public21461444616.85
As of Sep 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp. 5,00007-May-1990100026000009100000

1: 2 Bonus Issue04-Jan-19941000455000013650000

1:3 Bonus Issue14-Jan-19991000455000018200000

Stock Split29-Jan-19995001820000036400000

2:1 Rights @ 50021-Jun-200050072800000109200000

Stock Split 1 : 431-Aug-2001100436800000546000000

Right Conversion05-Aug-2002100182000000728000000

Right Issue 4 : 327-Nov-2017100--

Right Conversion07-Dec-20171002111424730111424

Right Conversion08-Dec-2017100997110731108534

Right Conversion11-Dec-20171005232281736340815

Right Conversion12-Dec-20171003028245501039165365

Right Conversion14-Dec-20171001011039165466

Right Conversion18-Dec-20171002348345341274000000
Other infos

Created date
2023-11-08 14:18:42
Revised date
2023-11-08 14:18:42
Finance
 
PT. Millennium Pharmacon International Tbk
 
2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013,
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year